RecruitingNot ApplicableNCT07416786

Validation of NAD+ Measurements for Human Clinical Studies

Validation of NAD+ Measurements for Human Clinical Studies: Multi-method Inter-laboratory Standardization

Sponsor

University of Pennsylvania

Enrollment

48 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Healthy Adults

Summary

The purpose of this study is to determine nicotinamide adenine dinucleotide (NAD) levels in healthy adult subjects before and after supplementing with over-the counter nicotinamide riboside (NR) using magnetic resonance spectroscopy (MRS).

Eligibility

Min Age: 18 YearsMax Age: 110 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Oral NR Supplementation for people with healthy adults. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 110 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.